Live Breaking News & Updates on Volker Knappertz

Stay updated with breaking news from Volker knappertz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aurinia Submits IND Application to US Food & Drug Administration for AUR 200

AUR200, a potent recombinant fusion protein, has a clinically validated MOA with a high affinity for targeting both BAFF and APRIL

Upon FDA clearance of the IND, AUR 200 will be studied in a. ....

Maryland , United-states , Rockville , Volker-knappertz , Research-development , Nasdaq , Drug-administration , American-college-of-rheumatology-convergence , Aurinia-pharmaceuticals , Aurinia-pharmaceuticals-inc , Investigational-new-drug , B-cell-activating-factor

Aurinia Pharmaceuticals (AUPH) Submits IND Application to the FDA for AUR 200

Aurinia Pharmaceuticals (AUPH) Submits IND Application to the FDA for AUR 200
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Volker-knappertz , American-college-of-rheumatology-convergence , Aurinia-pharmaceuticals-inc , Research-development , Drug-administration , Nasdaq , Aurinia-pharmaceuticals , Investigational-new-drug , B-cell-activating-factor , Proliferation-inducing-ligand , Executive-vice-president , American-college

Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Rockville , Maryland , United-states , United-kingdom , British , Dede-sheel , Volker-knappertz , Aurinia-pharmaceuticals-inc , Aurinia-pharmaceuticals , Company-compensation-committee , Nasdaq , Compensation-committee

Aurinia Announces the Addition of Three Seasoned Executive Leaders to Advance Company Strategy and P

Volker Knappertz, MD, as Executive Vice President, Research and Development, to lead the consolidated R&D function and to further enhance and advance the Aurinia pipelineScott Habig, as Chief Commercial Officer, to lead and enhance Aurinia’s commercial capabilities, replacing Max Colao, who led the formation of the. ....

Rockville , Maryland , United-states , United-kingdom , America , British , Robertb-huizinga , Volker-knappertz , Peter-greenleaf , Dede-sheel , Neil-solomons , Scott-habig

Why Aurinia Pharmaceuticals Stock Is In Retreat Today

Investors are none too pleased with the company's recent slew of hires. ....

Dede-sheel , Volker-knappertz , Scott-habig , Aurinia-pharmaceuticals ,